Physician
Retina Macula Specialists of Miami LLC
Retina Macula Specialists of Miami LLC was paid $914K by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 37% of everything it billed.
33Billing provider infoRETINA MACULA SPECIALISTS OF MIAMI LLC
NORTH MIAMI BEACH, FL 33162
NORTH MIAMI BEACH, FL 33162
33aNPI1982946612assigned 03/20/2013
33bProvider typeOphthalmology Physician
28Total paid$914K
24GClaims102,460
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Florida
Rank by total paid#5 of 262
Median peer was paid$9K
This provider vs. median105×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,768 | $63K | |
| 2019 | 20,735 | $246K | |
| 2020 | 15,354 | $197K | |
| 2021 | 17,626 | $203K | |
| 2022 | 13,317 | $148K | |
| 2023 | 13,618 | $31K | |
| 2024incomplete | 7,042 | $26K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 37% | 3,442 | 2,095 | $334K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 18% | 7,485 | 4,413 | $166K |
| 92134 | 15% | 14,523 | 8,773 | $138K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 12% | 12,997 | 7,293 | $105K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 8.0% | 3,265 | 2,121 | $74K |
| 4177F | 3.5% | 3,975 | 2,806 | $32K | |
| 92250 | 2.5% | 3,098 | 1,802 | $23K | |
| 2022F | 1.0% | 2,182 | 1,617 | $10K | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 8,991 | 6,135 | $7K |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | <1% | 3,892 | 2,606 | $7K |
| J2778 | Injection, ranibizumab, 0.1 mg | <1% | 345 | 151 | $6K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 8,044 | 5,955 | $4K |
19 more codes
| J7999 | Compounded drug, not otherwise classified | <1% | 2,172 | $2K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 198 | $2K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 363 | $2K |
| 93886 | <1% | 235 | $1K | |
| J9999 | Not otherwise classified, antineoplastic drugs | <1% | 162 | $577.90 |
| 93892 | <1% | 231 | $533.85 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 8,989 | $234.55 |
| 1036F | <1% | 9,213 | $90.76 | |
| J3490 | Unclassified drugs | <1% | 1,870 | $41.60 |
| 93890 | <1% | 235 | $23.07 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 809 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 579 | $0.00 |
| 92226 | 0% | 64 | $0.00 | |
| 2024F | 0% | 2,089 | $0.00 | |
| 2026F | 0% | 2,050 | $0.00 | |
| 92225 | 0% | 56 | $0.00 | |
| 5010F | 0% | 843 | $0.00 | |
| 76512 | 0% | 20 | $0.00 | |
| 0517F | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEVY, J. (MANAGING PARTNER)